Optimize your high value cell lines

What you will find in this eBook

During the last decade, production of monoclonal antibodies (mAbs) and recombinant proteins using mammalian cells has led to a boom in the introduction of biotherapeutic proteins to the market. As growth continues, the need to bring down cell line development costs and shorten the time to market is more critical than ever.

In this eBook, we present an overview of the cell line development workflow as well as high throughput solutions for accelerating the process, and enabling easier and faster selection of high-producing mammalian cell lines.

Sample pages

Recombinant protein workflow

Hybridoma selection using HAT

Monoclonal antibodies

GPCRs

Cell surface protein expression